James Roach has been appointed chief medical officer of Lexington, MA-based Pulmatrix (NASDAQ: [[ticker:PULM]]). Roach joins Pulmatrix from Southborough, MA-based Veristat, where he was chief medical officer. Pulmatrix develops inhaled drugs for serious lung diseases. Roach will start his new role on Nov. 3.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
